Biobank Graz, Austria

Registration Status: Pending

Objective: Biobank Graz is a central research infrastructure integrated at the Medical University of Graz responsible for collecting, processing, storing and delivering high quality biological samples and associated data. The overall collection includes, among others, formalin-fixed paraffin-embedded (FFPE) tissues, cryopreserved tissues and biological fluids. The facility is ISO 9001:2015 certified and a part of its biological fluids collection meets CEN/TS requirements. All samples and data are anonymized and processed according to standard operation procedures. Biobank Graz provides managerial support (e.g. project implementation) as well as technical support (e.g. preparation of derivatives) to academic and industrial research.

Registered Biobank Name	Biobank Graz
Biobank Leader	Christian GÃ¼lly
Country	Austria
Email for biobank inquiries	biobank@medunigraz.at
Principal Investigator	Christian GÃ¼lly
Website	http://www.medunigraz.at/en/forschen/organisation-und-services/biobank-graz/
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).